Mu Hao
Impact in
- Hematology top 2%
- Multiple Myeloma Research and Treatments
- Cancer Research top 10%
- MicroRNA in disease regulation
Papers in
- Hematology 51
- Multiple Myeloma Research and Treatments 50
-
- Protein Degradation and Inhibitors 13
- Ubiquitin and proteasome pathways 7
- Co-authors
- Lugui Qiu (60 shared papers)Gang An (46 shared papers)Yan Xu (32 shared papers)Shuhui Deng (31 shared papers)Weiwei Sui (27 shared papers)Dehui Zou (23 shared papers)Fei Li (13 shared papers)Fenghuang Zhan (17 shared papers)
- Journals
- Blood (20 papers)Oncotarget (5 papers)Leukemia Research (3 papers)Haematologica (3 papers)Leukemia (3 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Mu Hao
87 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 80
- Hematology 566
- Cancer Research 255
- Genetics 153
- Oncology 324
- Molecular Biology 631
Countries citing papers authored by Mu Hao
This map shows the geographic impact of Mu Hao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mu Hao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mu Hao more than expected).
Fields of papers citing papers by Mu Hao
This network shows the impact of papers produced by Mu Hao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mu Hao. The network helps show where Mu Hao may publish in the future.
Co-authors
The 25 scholars most cited alongside Mu Hao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 95 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 92 | |
| 2 | 2016 | 84 | |
| 3 | 2018 | 71 | |
| 4 | 2016 | 66 | |
| 5 | 2015 | 65 | |
| 6 | 2014 | 58 | |
| 7 | 2015 | 53 | |
| 8 | 2014 | 50 | |
| 9 | 2013 | 48 | |
| 10 | 2015 | 46 | |
| 11 | 2016 | 45 | |
| 12 | 2013 | 42 | |
| 13 | 2015 | 41 | |
| 14 | 2020 | 36 | |
| 15 | 2010 | 35 | |
| 16 | 2019 | 34 | |
| 17 | 2022 | 28 | |
| 18 | 2021 | 26 | |
| 19 | 2020 | 23 | |
| 20 | 2015 | 22 |
About Mu Hao
Mu Hao is a scholar working on Hematology, Molecular Biology, Oncology, Cancer Research and Genetics, having authored 95 papers that have together received 1.3k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (50 papers), Protein Degradation and Inhibitors (13 papers), Peptidase Inhibition and Analysis (11 papers), MicroRNA in disease regulation (11 papers), Chronic Lymphocytic Leukemia Research (8 papers), Ubiquitin and proteasome pathways (7 papers), Cancer Mechanisms and Therapy (6 papers) and Chemokine receptors and signaling (5 papers). The work is most often cited by research in Hematology (566 citations), Cancer Research (255 citations), Genetics (153 citations), Oncology (324 citations) and Molecular Biology (631 citations). Mu Hao has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Lugui Qiu, Gang An, Yan Xu, Shuhui Deng, Weiwei Sui, Dehui Zou, Fei Li, Fenghuang Zhan, Ye Yang and Shuhua Yi. Their work appears in journals such as Blood, Oncotarget, Leukemia Research, Haematologica and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.